|
Volumn 24, Issue 4, 2009, Pages 1338-1340
|
Therapy-resistant anaemia in congenital nephrotic syndrome of the Finnish type-implication of EPO, transferrin and transcobalamin losses
|
Author keywords
Congenital nephrotic syndrome of the Finnish type; Erythropoietin; Transcobalamin; Transferrin
|
Indexed keywords
ALBUMIN;
CYANOCOBALAMIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
IMMUNOGLOBULIN;
IRON;
LEVOTHYROXINE;
RECOMBINANT ERYTHROPOIETIN;
TRANSCOBALAMIN;
TRANSFERRIN;
WARFARIN;
ANEMIA;
ARTICLE;
BLOOD TRANSFUSION;
CASE REPORT;
CLINICAL FEATURE;
CONGENITAL NEPHROTIC SYNDROME;
CONTINUOUS INFUSION;
DISEASE MARKER;
DISEASE SEVERITY;
DRUG DOSE INCREASE;
DRUG EFFICACY;
DRUG ELIMINATION;
ERYTHROPOIESIS;
FEMALE;
GESTATIONAL AGE;
HUMAN;
HYPOTHYROIDISM;
INFANT;
IRON THERAPY;
PRIORITY JOURNAL;
PROTEINURIA;
SINGLE DRUG DOSE;
TRANSFERRIN BLOOD LEVEL;
URINARY EXCRETION;
VITAMIN SUPPLEMENTATION;
ANEMIA;
BLOOD TRANSFUSION;
ERYTHROPOIETIN;
FEMALE;
HEMATINICS;
HUMANS;
INFANT, NEWBORN;
NEPHRECTOMY;
NEPHROTIC SYNDROME;
TRANSCOBALAMINS;
TRANSFERRIN;
|
EID: 65349168512
PISSN: 09310509
EISSN: 14602385
Source Type: Journal
DOI: 10.1093/ndt/gfn762 Document Type: Article |
Times cited : (15)
|
References (10)
|